Wealth Watch: Markets Find Their Feet  After Several Days Of Pullback; HCM-BUYLINE® Remains Positive

Wealth Watch: Markets Find Their Feet After Several Days Of Pullback; HCM-BUYLINE® Remains Positive

September 16, 2021
Share |

From the desk of Vance Howard:

The HCM-BuyLine® is positive, so the trend is still very much intact. The market as whole is…let’s just say tired. There is not a lot of upward momentum, and some of that is due to the massive tax increase that is being batted around congress. It appears the moderates in the house are pushing for more of a realistic tax increase, but let there be no doubt, they are going to raise taxes. Will it be so high it stops the economic recovery? I have stated over and over that taxation and overregulation will halt the recovery. The last announcement on the tax increase did not include any change in the SALT tax issue, and we see this as a real sticking point for some Democrats in voting for the tax increase. It is our opinion that it will be at least adjusted, if not entirely repealed, before the tax package is passed. 


SPY

The S&P 500, as shown in the chart of SPY, is in a clear uptrend and has pulled back to the 50-day MA, which should act as support. This is consistent with a strong bull market. Are we overdue for a correction? To be honest, yes. But trying to guess when that correction will be is a waste of time. When, and I repeat when we get a correction, it will probably be short-lived even if it is a full 10% correction. 


SOXX

Lots of indexes and stocks are trying to break out. The semiconductor index ETF SOXX continues to move higher, and I must admit it has been a sloppy trade, but it continues to march higher. So not pretty, but still working. 


LULU

Lululemon (LULU) has staged a classic William O’Neal breakout and should move higher near-team. 


 VBK

We have been watching VBK, Vanguard’s small cap growth ETF, and it looks like it is trying hard to break out. It came down and is sitting on its 50-day MA which is acting as support. Small cap growth has struggled all year, and maybe it is time for a catch-up trade, but we will wait and see. 

IBB

Biotech (IBB) has pulled back slightly the last few days and is now oversold on a short-term basis. We believe this sector could make a good move higher into the end of the year. 

Thanks,

Vance Howard


Copyright © 2021, All rights reserved.

Our mailing address is:

Howard Capital Management Inc.
1145 Hembree Rd
Roswell, GA 30076

This newsletter is a publication of Howard Capital Management, Inc. It should not be regarded as a complete analysis of the subjects discussed nor should the newsletter be construed as personalized investment advice. All expressions of opinion reflect the judgment of the authors as of the date of publication and are subject to change. It should not be viewed as legal or tax advice. Always consult an attorney or tax professional regarding your specific legal or tax situation.

Please remember that past performance may not be indicative of future results. Different types of investments involve varying degrees of risk, and there can be no assurance that the future performance of any specific investment, investment strategy, or product (including the investments and/or investment strategies recommended or undertaken by Howard Capital Management, Inc. (“HCM”), or any non-investment related content, made reference to directly or indirectly in this commentary will be profitable, equal any corresponding indicated historical performance level(s), be suitable for your portfolio or individual situation, or prove successful. Due to various factors, including changing market conditions and/or applicable laws, the content may no longer be reflective of current opinions or positions. Moreover, you should not assume that any discussion or information contained in this commentary serves as the receipt of, or as a substitute for, personalized investment advice from HCM. Please remember to contact your primary investment professional, in writing, if there are any changes in your personal/financial situation or investment objectives for the purpose of reviewing/evaluating/revising HCM’s investment management services, or if you would like to impose, add, or to modify any reasonable restrictions to our investment management services. HCM is neither a law firm nor a certified public accounting firm and no portion of the commentary content should be construed as legal or accounting advice. A copy of the HCM’s current written disclosure Brochure discussing our advisory services and fees continues to remain available upon request.

© 2021 Howard Capital Management, Inc. All rights reserved. Intended for receipt only and not for further distribution without the consent of Howard Capital Management, Inc.

McCarthy Financial Group's Blog: Market Insights & Wealth Watch

Schedule Appointment